Allplex™ MTB/MDRe Detection is a multiplex real-time PCR assay that detect Mycobacterium tuberculosis (MTB) with Ct value and identify 25 mutations associated with MDR-TB simultaneously. Based on Seegene's proprietary DPO™ and TOCE™ technology, this assay allows providing prompt diagnosis and appropriate treatment guideline for tuberculosis control.
Key Features and Benefits
-
DNA extraction solution
Reagent for DNA Detection is provided, purchase of DNA extraction kit is unnecessary[1]
-
Multiplex real-time PCR
Simultaneous detection of Mycobacterium tuberculosis and 25 mutations associated with MDR-TB
-
Prediction of antibiotic resistance
Detection and identification of mutations associated antibiotic resistance for appropriate infection control
-
User-friendly workflow
Convenient workflow using Seegene’s automated one platform
-
Automatic data analyzer
Automated data interpretation and LIS interlocking with Seegene Viewer
-
Fast treatment decision
Fast treatment decision by simultaneous screening and detection of antibiotic resistance
-
UDG system
Utilization of the UDG system to prevent carry-over contamination
-
Proper patient care
Quick and proper treatment provided by accurate test results
-
Analytes
-
Specimens
- Sputum
- Bronchial washing
- Cultured cell
-
Ordering Information
ProductCat No. / SizeAllplex™ MTB/MDRe DetectionTB10386Z / 25 rxns
TB9400X / 100 rxns
Result
Multiple Ct value in a single channel
The result represents detection of MTB with Isoniazid-Resistance in FAM and CalRed 610 channel. The ct value of MTB is 33.83
Note
[1] Excluded when applied on automation system
[2] The WTC is designed to be exhibited the same result pattern with drug-susceptible M. tuberculosis sample. The WTC reaction should be always performed in each testing run, and the drug-resistant result of unknown samples is analyzed on the basis of the result of WTC.
[3] Multi-Drug Resistance